Jeffrey Lee Boerneke
CIK: 0002162676
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ASPE
Aspen Neuroscience, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Boerneke Jeffrey Lee
Boerneke Jeffrey Lee (SEC CIK 0002162676) files insider reports with the SEC as General Counsel and Secretary of Aspen Neuroscience, Inc. (ASPE).
Signal8 holds 1 ownership filing by Boerneke Jeffrey Lee, a Form 3, filed on Oct 29, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Boerneke Jeffrey Lee's filings is in SAN DIEGO, CA.
Other insiders filing for Aspen Neuroscience, Inc. (ASPE)
- ARCH Venture Fund X, L.P., 10% Owner
- ARCH Venture Partners XIV, L.P., 10% Owner
- Spaventa Andrew, Director
- Hasnain Faheem, Executive Chair
- ORBIMED ADVISORS LLC, Director
- Daniel Thomas O, Director